PuSH - Publikationsserver des Helmholtz Zentrums München

Klinger, B.* ; Rausch, I.* ; Sieber, A.* ; Kutz, H. ; Kruse, V.* ; Kirchner, M.* ; Mertins, P.* ; Kieser, A. ; Blüthgen, N.* ; Kube, D.*

Quantitative modeling of signaling in aggressive B cell lymphoma unveils conserved core network.

PLoS Comput. Biol. 20:e1012488 (2024)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
B cell receptor (BCR) signaling is required for the survival and maturation of B cells and is deregulated in B cell lymphomas. While proximal BCR signaling is well studied, little is known about the crosstalk of downstream effector pathways, and a comprehensive quantitative network analysis of BCR signaling is missing. Here, we semi-quantitatively modelled BCR signaling in Burkitt lymphoma (BL) cells using systematically perturbed phosphorylation data of BL-2 and BL-41 cells. The models unveiled feedback and crosstalk structures in the BCR signaling network, including a negative crosstalk from p38 to MEK/ERK. The relevance of the crosstalk was verified for BCR and CD40 signaling in different BL cells and confirmed by global phosphoproteomics on ERK itself and known ERK target sites. Compared to the starting network, the trained network for BL-2 cells was better transferable to BL-41 cells. Moreover, the BL-2 network was also suited to model BCR signaling in Diffuse large B cell lymphoma cells lines with aberrant BCR signaling (HBL-1, OCI-LY3), indicating that BCR aberration does not cause a major downstream rewiring.
Impact Factor
Scopus SNIP
Altmetric
3.800
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Colon-cancer; Receptor; Feedback; Kinase; Erk; Pathogenesis; Inhibition; Activation; Mechanisms; Expression
Sprache englisch
Veröffentlichungsjahr 2024
HGF-Berichtsjahr 2024
ISSN (print) / ISBN 1553-734X
e-ISSN 1553-7358
Quellenangaben Band: 20, Heft: 10, Seiten: , Artikelnummer: e1012488 Supplement: ,
Verlag Public Library of Science (PLoS)
Verlagsort 1160 Battery Street, Ste 100, San Francisco, Ca 94111 Usa
Begutachtungsstatus Peer reviewed
Institut(e) Research Unit Gene Vector (AGV)
Research Unit Signaling and Translation (SAT)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Immune Response and Infection
Enabling and Novel Technologies
PSP-Element(e) G-501500-001
G-501500-005
G-509800-004
Förderungen Bundesinstitut fur Risikobewertung
DKFZ (Young Investigator Grant)
Deutsche Krebshilfe
MSTARS-2
Federal Ministry of Education and Research (BMBF)
Scopus ID 85205602890
PubMed ID 39352924
Erfassungsdatum 2024-11-04